LV10612B - Method for producing of 1-benzyl-3-oxy-methylindazole, it's salts and pharmaceutically acceptable carrier - Google Patents
Method for producing of 1-benzyl-3-oxy-methylindazole, it's salts and pharmaceutically acceptable carrier Download PDFInfo
- Publication number
- LV10612B LV10612B LVP-93-647A LV930647A LV10612B LV 10612 B LV10612 B LV 10612B LV 930647 A LV930647 A LV 930647A LV 10612 B LV10612 B LV 10612B
- Authority
- LV
- Latvia
- Prior art keywords
- hjih
- quot
- pharmaceutically acceptable
- salts
- benzyl
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract 4
- 239000003937 drug carrier Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract 3
- 238000002360 preparation method Methods 0.000 claims abstract 2
- 101000687448 Homo sapiens REST corepressor 1 Proteins 0.000 claims description 2
- 102100024864 REST corepressor 1 Human genes 0.000 claims description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 229940125904 compound 1 Drugs 0.000 description 4
- 101150096418 Mepe gene Proteins 0.000 description 2
- 101000650578 Salmonella phage P22 Regulatory protein C3 Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 101001040920 Triticum aestivum Alpha-amylase inhibitor 0.28 Proteins 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 241001669680 Dormitator maculatus Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 241000269435 Rana <genus> Species 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8947620A IT1230441B (it) | 1989-02-07 | 1989-02-07 | Eteri della serie dell'indazolo |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV10612A LV10612A (lv) | 1995-04-20 |
| LV10612B true LV10612B (en) | 1995-08-20 |
Family
ID=11261479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-93-647A LV10612B (en) | 1989-02-07 | 1993-06-22 | Method for producing of 1-benzyl-3-oxy-methylindazole, it's salts and pharmaceutically acceptable carrier |
Country Status (36)
| Country | Link |
|---|---|
| US (2) | US4999367A (OSRAM) |
| EP (1) | EP0382276B1 (OSRAM) |
| JP (1) | JP2870925B2 (OSRAM) |
| KR (1) | KR0145525B1 (OSRAM) |
| CN (2) | CN1046505C (OSRAM) |
| AR (1) | AR247386A1 (OSRAM) |
| AT (1) | ATE127115T1 (OSRAM) |
| AU (1) | AU624895B2 (OSRAM) |
| BG (1) | BG50273A3 (OSRAM) |
| CA (1) | CA2009503C (OSRAM) |
| CZ (1) | CZ280121B6 (OSRAM) |
| DD (2) | DD291995A5 (OSRAM) |
| DE (2) | DE382276T1 (OSRAM) |
| DK (1) | DK0382276T3 (OSRAM) |
| EG (1) | EG19170A (OSRAM) |
| ES (1) | ES2020171T3 (OSRAM) |
| FI (1) | FI102678B (OSRAM) |
| GE (1) | GEP19971030B (OSRAM) |
| GR (2) | GR910300073T1 (OSRAM) |
| HU (1) | HU204793B (OSRAM) |
| IL (1) | IL93132A (OSRAM) |
| IN (1) | IN170957B (OSRAM) |
| IT (1) | IT1230441B (OSRAM) |
| LT (1) | LT3604B (OSRAM) |
| LV (1) | LV10612B (OSRAM) |
| NZ (1) | NZ232258A (OSRAM) |
| PE (1) | PE25091A1 (OSRAM) |
| PH (1) | PH26552A (OSRAM) |
| PL (2) | PL163720B1 (OSRAM) |
| PT (1) | PT93067B (OSRAM) |
| RO (1) | RO106252B1 (OSRAM) |
| RU (3) | RU2066318C1 (OSRAM) |
| SK (1) | SK56390A3 (OSRAM) |
| UA (1) | UA26852C2 (OSRAM) |
| YU (1) | YU47943B (OSRAM) |
| ZA (1) | ZA90644B (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1253703B (it) * | 1991-04-22 | 1995-08-23 | Angelini Francesco Ist Ricerca | Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie |
| IT1293795B1 (it) * | 1997-07-28 | 1999-03-10 | Angelini Ricerche Spa | Farmaco attivo nel ridurre la produzione di proteina mcp-1 |
| US5943270A (en) * | 1997-11-26 | 1999-08-24 | Intel Corporation | Two-transistor DRAM cell for logic process technology |
| US7514463B2 (en) | 2004-08-20 | 2009-04-07 | University Of Kansas | Lonidamine analogues and their use in male contraception and cancer treatment |
| ITMI20062254A1 (it) | 2006-11-24 | 2008-05-25 | Acraf | Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca |
| MX2010009624A (es) | 2008-03-07 | 2010-09-28 | Acraf | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1. |
| MX2010009625A (es) | 2008-03-07 | 2010-09-28 | Acraf | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40. |
| GEP20135983B (en) * | 2008-03-07 | 2013-12-10 | Acraf | 1-benzyl-3-hydroxymethylindazole derivatives and usage therein treatment of diseases based on mcp-1, cx3cr1 and p40 expression |
| SI2462118T1 (sl) * | 2009-08-03 | 2014-10-30 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Postopek za pripravo 1-benzil-3-hidroksimetil-1H-indazola in njegovih derivatov ter potrebni magnezijevi intermediati |
| UA108742C2 (uk) | 2009-09-23 | 2015-06-10 | Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1 | |
| US8999292B2 (en) | 2012-05-01 | 2015-04-07 | Translatum Medicus Inc. | Methods for treating and diagnosing blinding eye diseases |
| WO2013163758A1 (en) | 2012-05-01 | 2013-11-07 | Boyd Shelley Romayne | Methods for treating and diagnosing blinding eye diseases |
| WO2013171316A1 (en) | 2012-05-18 | 2013-11-21 | Sanofi | Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation |
| PT2882715T (pt) | 2012-05-18 | 2016-12-30 | Sanofi Sa | Derivados de pirazol e seu uso como antagonistas de lpar5 |
| CN108047136B (zh) * | 2017-12-20 | 2021-07-09 | 长春普华制药股份有限公司 | 一种苄达酸的精制方法 |
| WO2020261158A1 (en) | 2019-06-25 | 2020-12-30 | Translatum Medicus Inc. | Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives |
| CN113929627A (zh) * | 2021-10-19 | 2022-01-14 | 吕梁学院 | 一种宾达利的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL28032A (en) * | 1966-08-29 | 1971-08-25 | Acraf | Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof |
| US3470298A (en) * | 1969-01-29 | 1969-09-30 | Acraf | Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids |
| IT1131779B (it) | 1980-07-29 | 1986-06-25 | Acraf | Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione |
| IT1189052B (it) | 1981-11-27 | 1988-01-28 | Acraf | Trattamento della cataratta |
| IT1194564B (it) | 1983-04-18 | 1988-09-22 | Acraf | Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa |
| IT1197805B (it) | 1986-08-01 | 1988-12-06 | Acraf | Metodo per il tratamento di lenti a contatto |
-
1989
- 1989-02-07 IT IT8947620A patent/IT1230441B/it active
-
1990
- 1990-01-22 IL IL9313290A patent/IL93132A/en not_active IP Right Cessation
- 1990-01-23 EP EP90200167A patent/EP0382276B1/en not_active Expired - Lifetime
- 1990-01-23 AT AT90200167T patent/ATE127115T1/de not_active IP Right Cessation
- 1990-01-23 DE DE199090200167T patent/DE382276T1/de active Pending
- 1990-01-23 ES ES90200167T patent/ES2020171T3/es not_active Expired - Lifetime
- 1990-01-23 DE DE69021902T patent/DE69021902T2/de not_active Expired - Lifetime
- 1990-01-23 DK DK90200167.6T patent/DK0382276T3/da active
- 1990-01-24 US US07/470,118 patent/US4999367A/en not_active Expired - Lifetime
- 1990-01-26 NZ NZ232258A patent/NZ232258A/en unknown
- 1990-01-29 ZA ZA90644A patent/ZA90644B/xx unknown
- 1990-01-30 PE PE1990164654A patent/PE25091A1/es unknown
- 1990-01-30 IN IN81/CAL/90A patent/IN170957B/en unknown
- 1990-02-02 AU AU49066/90A patent/AU624895B2/en not_active Expired
- 1990-02-05 PL PL90283638A patent/PL163720B1/pl unknown
- 1990-02-05 RO RO144074A patent/RO106252B1/ro unknown
- 1990-02-05 PL PL90285287A patent/PL163730B1/pl unknown
- 1990-02-05 YU YU20690A patent/YU47943B/sh unknown
- 1990-02-06 FI FI900577A patent/FI102678B/fi active IP Right Grant
- 1990-02-06 SK SK563-90A patent/SK56390A3/sk not_active IP Right Cessation
- 1990-02-06 UA UA4743128A patent/UA26852C2/uk unknown
- 1990-02-06 PT PT93067A patent/PT93067B/pt active IP Right Grant
- 1990-02-06 EG EG6290A patent/EG19170A/xx active
- 1990-02-06 RU SU904743128A patent/RU2066318C1/ru active
- 1990-02-06 CZ CS90563A patent/CZ280121B6/cs not_active IP Right Cessation
- 1990-02-06 HU HU90689A patent/HU204793B/hu unknown
- 1990-02-06 JP JP2027007A patent/JP2870925B2/ja not_active Expired - Lifetime
- 1990-02-06 PH PH40002A patent/PH26552A/en unknown
- 1990-02-06 BG BG091122A patent/BG50273A3/xx unknown
- 1990-02-06 AR AR90316095A patent/AR247386A1/es active
- 1990-02-07 KR KR1019900001453A patent/KR0145525B1/ko not_active Expired - Fee Related
- 1990-02-07 DD DD90337657A patent/DD291995A5/de unknown
- 1990-02-07 DD DD90342349A patent/DD295363A5/de unknown
- 1990-02-07 CN CN90100599A patent/CN1046505C/zh not_active Expired - Fee Related
- 1990-02-07 CA CA002009503A patent/CA2009503C/en not_active Expired - Lifetime
- 1990-12-20 US US07/632,117 patent/US5112986A/en not_active Expired - Lifetime
-
1991
- 1991-06-05 RU SU914895540A patent/RU2044729C1/ru active
- 1991-06-05 RU SU914895526A patent/RU2055071C1/ru active
- 1991-11-15 GR GR91300073T patent/GR910300073T1/el unknown
-
1993
- 1993-06-22 LV LVP-93-647A patent/LV10612B/lv unknown
- 1993-07-26 GE GEAP19931214A patent/GEP19971030B/en unknown
- 1993-08-17 LT LTIP872A patent/LT3604B/lt not_active IP Right Cessation
- 1993-09-15 CN CN93117740A patent/CN1034016C/zh not_active Expired - Fee Related
-
1995
- 1995-11-22 GR GR950403284T patent/GR3018165T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV10612B (en) | Method for producing of 1-benzyl-3-oxy-methylindazole, it's salts and pharmaceutically acceptable carrier | |
| US3369025A (en) | 3-pyridylmethyl phenoxy (phenylthio and anilino) alkanoates | |
| RU2001904C1 (ru) | Способ получени хиноновых производных | |
| USRE32581E (en) | Certain substituted phenyl esters of nicotinic acid, compositions and methods of using same for treatment of hyperlipidemia | |
| IL62485A (en) | Glycerol-3-phosphoric acid halogenoalkyl esters and processes for their preparation and further conversion to phospholipids | |
| HUT58312A (en) | Process for producing new 4-quinolyl-dihydropyridine derivatives and pharmaceutical compositions containing them | |
| SU604481A3 (ru) | Способ получени производных простых аминоалкилфениловых эфиров или их солей | |
| Yoshimura et al. | Steric Difference between the Substitution Reaction Products of Lithium Alkyls and Grignard Reagents with α-Aminonitriles. 1 An Asymmetric Reproduction | |
| EP1617843B1 (en) | Colchicine derivatives | |
| DE2050484B2 (de) | Verfahren zu deren Herstellung | |
| JPS56142236A (en) | Ml-236a and mb-530a derivative | |
| US3989738A (en) | Method of preparing phenolic antioxidants by condensing active methylene compounds with 3,5-di-tert alkyl-4-hydroxybenzylpyridinium salts | |
| IL95272A0 (en) | Esters of organic acids with alcohol derivatives of 19-nor steroids and their salts,process of preparation and pharmaceutical compositions containing them | |
| Kokosa et al. | Deoxidative substitution of pyridine N-oxides. XII. Revised structures of some tetrahydropyridines isolated from the reaction of pyridine N-oxides with mercaptans and acid anhydrides | |
| HIGUCHI et al. | Chemistry of Succinimido Esters. IV. A Facile Preparation of N-Succinimidyl Carboxylates Using N, N'-Disuccinimidyl Carbonate | |
| DE1468422A1 (de) | Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden | |
| US4086343A (en) | Acylated hydrazinopyridazine antihypertensives | |
| JPS56161388A (en) | Novel vincamine derivative | |
| US3271402A (en) | Carbon-z-thiobarbituric acids | |
| JPS55100356A (en) | Benzenediol derivative | |
| Costantino et al. | The stereochemistry of crasserides | |
| US3468951A (en) | Bis-(alkoxyaryl)alkyl-n-alkenyl-and-alkynyl-amines | |
| US2653157A (en) | p-amino-salicylic acid derivatives and their production | |
| JPS5782390A (en) | Carbostyril derivative | |
| JPS5655383A (en) | Amizine derivative and its preparation |